Stocks › LLY
Eli Lilly and Co LLY
US equityMarket cap rank #13
$1,354.00 −$10.73 (-0.79%)
Market closed · Nov 7, 9:50 pm ET · Last extended-hours $1,357.00 +0.22%
Open$1,350.45
Prev close$1,364.73
Day range$1,333.22 – $1,377.28
Volume3.81M
Market cap$1.27T
P/E (TTM)43.9
Dividend yield0.49%
LLY Stock News
Headlines matching Eli Lilly and Co or the LLY ticker, most recent first.
- Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400
- News On AtaiBeckley Inc. (ATAI) Now Under LLY
- BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400
- U.S. Stock Market Movements | Eli Lilly and Co (LLY.US) Rises 1.69% as Alzheimer's Blood Test Wins FDA Approval Positive
- Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400
- BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400
- Direxion Daily LLY Bull 2X Shares | NPORT-P: Others
- Defiance Daily Target 2X Long LLY ETF | NPORT-P: Others
- Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400
- J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,500 Positive
- UBS Group: InnoCare Pharma (09969) reaches collaboration agreement with Eli Lilly and Co (LLY.US) on innovative target projects; maintains positive view
- Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
- Wells Fargo Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,330
- Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,440
- TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,250
No comments yet — be the first to weigh in on LLY.
Sign in to join the discussion.